Introduction to Therapeutic Antibodies
The MorphoSys HuCAL-based technologies support the discovery and development of fully human monoclonal antibodies for therapeutic, diagnostic and research applications.
HuCAL GOLD features…
- Rapid generation of fully human antibodies
- Technically mature, reliable technology, with proven success for difficult antigens (e.g. non-immunogenic or toxic antigens)
- Modular library construction allowing systematic optimization (affinity, specificity, format)
- Excellent conversion from the Fab to IgG formats (stability, clear monomeric or bivalent format, functionality, productivity)
MorphoSys offers its partners…
For customers who prefer an in-house solution, MorphoSys offers the installment of the HuCAL GOLD library and technology at the partners’ premises, including the MorphoSys specialized customer support to ensure the most effective utilization of the HuCAL technology. For those clients who prefer external services, MorphoSys offers antibody generation by its experts according to the pre-defined specifications of its customers. Additionally, MorphoSys develops proprietary therapeutic antibody candidates that are available for partnering.
MorphoSys as a business partner…
… supports its customers to achieve better, faster and more sustainable results. MorphoSys focuses on many of the intangibles that make the difference in achieving tangible results: a collaborative approach, knowledge sharing, goal sharing, and simpler, more effective processes. MorphoSys places great emphasis on the management of its partnerships, thereby investing significant effort in maintaining its long-term relationships through its alliance management. Furthermore, MorphoSys can offer its customers a solid IP environment on which to develop and commercialize antibodies based on the MorphoSys proprietary HuCAL GOLD technology.